LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 112 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.53 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,977 | -18.0% | 16,493 | +72.4% | 0.00% | – |
| Q2 2023 | $21,911 | -77.9% | 9,568 | -55.5% | 0.00% | – |
| Q2 2021 | $99,000 | -13.2% | 21,505 | +10.7% | 0.00% | – |
| Q1 2021 | $114,000 | +7.5% | 19,422 | -37.3% | 0.00% | – |
| Q4 2020 | $106,000 | -95.7% | 30,970 | -98.2% | 0.00% | -100.0% |
| Q3 2020 | $2,462,000 | -27.8% | 1,709,776 | 0.0% | 0.01% | -25.0% |
| Q2 2020 | $3,411,000 | +143.6% | 1,709,776 | +138.2% | 0.01% | +100.0% |
| Q1 2020 | $1,400,000 | +200.4% | 717,707 | +538.5% | 0.00% | +300.0% |
| Q4 2019 | $466,000 | +46500.0% | 112,397 | +158205.6% | 0.00% | – |
| Q3 2019 | $1,000 | -98.4% | 71 | -99.3% | 0.00% | – |
| Q2 2019 | $62,000 | -11.4% | 9,862 | -21.8% | 0.00% | – |
| Q1 2019 | $70,000 | +1066.7% | 12,611 | +1317.0% | 0.00% | – |
| Q4 2018 | $6,000 | -92.3% | 890 | -79.3% | 0.00% | – |
| Q3 2016 | $78,000 | – | 4,294 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $34,786,000 | 99.98% |
| Artal Group S.A. | 57,517,978 | $463,019,000 | 19.93% |
| MASTERS CAPITAL MANAGEMENT LLC | 1,129,708 | $9,094,000 | 0.30% |
| Rhenman & Partners Asset Management AB | 170,915 | $1,376,000 | 0.16% |
| Round Table Services, LLC | 21,611 | $174,000 | 0.14% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $287,000 | 0.10% |
| FALCON POINT CAPITAL, LLC | 37,039 | $298,000 | 0.10% |
| SABBY MANAGEMENT, LLC | 318,775 | $2,566,000 | 0.09% |
| WILLIAM HARRIS INVESTORS INC | 39,495 | $318,000 | 0.09% |
| HOWARD HUGHES MEDICAL INSTITUTE | 51,520 | $415,000 | 0.09% |